Variable | Lidocaine group n = 35 | Control group n = 36 | p-value |
---|---|---|---|
PONV | |||
number (%) | 17 (48.57%) | 22 (61.11%) | 0.29 |
PV | |||
number (%) | 16 (45.7%) | 18 (50.0%) | 0.72 |
Duration of PONV in patients with PONV | |||
Median (IQR) | 10.1 (5.13–18.75) | 14.2 (8.23–19.33) | 0.54 |
Patients who received Ondansetron | |||
number (%) | 8 (22.86%) | 12 (33.33%) | 0.33 |
Dose of ondansetron | |||
Median (IQR) | 3.5 (3.0–4.0) | 4.0 (4.0–4.0) | 0.32 |
Variable | Females n = 22 | Males = 49 | |
Number of patients who received Ondansetron | |||
number (%) | 6 (27.27%) | 14 (28.57%) | 0.91 |
Variable | Lidocaine group n = 35 | Control group n = 36 | p-value |
Length of hospital stay after extubation | |||
[days] Median (IQR) | 4 (4–5) | 4.5 (4–6) | 0.31 |
[hours] Median (IQR) | 96 (88–116) | 109 (87–141.5) | 0.41 |